1,722,679 research outputs found
sj-pdf-1-jmx-10.1177_00222429211033585 - Supplemental material for Identifying Market Structure: A Deep Network Representation Learning of Social Engagement
No full textSupplemental material, sj-pdf-1-jmx-10.1177_00222429211033585 for Identifying Market Structure: A Deep Network Representation Learning of Social Engagement by Yi Yang, Kunpeng Zhang and P.K. Kannan in Journal of Marketing</p
sj-docx-1-wso-10.1177_17474930221104991 – Supplemental material for Safety and efficacy of remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke: A multicenter, randomized, parallel-controlled clinical trial (SERIC-IVT) Study design and protocol
No full textSupplemental material, sj-docx-1-wso-10.1177_17474930221104991 for Safety and efficacy of remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke: A multicenter, randomized, parallel-controlled clinical trial (SERIC-IVT) Study design and protocol by Reziya Abuduxukuer, Zhen-Ni Guo, Peng Zhang, Yang Qu and Yi Yang in International Journal of Stroke</p
Supplementary_figure_2 - High <i>BIRC7</i> Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer
No full textSupplementary_figure_2 for High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer by Yi Yang, Peng Sun, Wei Xu, and Wei Xia in Technology in Cancer Research & Treatment</p
sj-docx-3-tag-10.1177_17562848221101722 – Supplemental material for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study
No full textSupplemental material, sj-docx-3-tag-10.1177_17562848221101722 for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study by Yubin Cao, Jiaming Feng, Shihao Duan, Yi Yang and Yan Zhang in Therapeutic Advances in Gastroenterology</p
sj-docx-2-imj-10.1177_10815589231184215 – Supplemental material for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis
No full textSupplemental material, sj-docx-2-imj-10.1177_10815589231184215 for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis by Yunji Leng, Xian Yu, Yi Yang and Yifan Xia in Journal of Investigative Medicine</p
sj-docx-3-imj-10.1177_10815589231184215 – Supplemental material for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis
No full textSupplemental material, sj-docx-3-imj-10.1177_10815589231184215 for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis by Yunji Leng, Xian Yu, Yi Yang and Yifan Xia in Journal of Investigative Medicine</p
sj-docx-1-imj-10.1177_10815589231184215 – Supplemental material for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis
No full textSupplemental material, sj-docx-1-imj-10.1177_10815589231184215 for Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: a meta-analysis by Yunji Leng, Xian Yu, Yi Yang and Yifan Xia in Journal of Investigative Medicine</p
sj-docx-2-tag-10.1177_17562848221101722 – Supplemental material for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study
No full textSupplemental material, sj-docx-2-tag-10.1177_17562848221101722 for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study by Yubin Cao, Jiaming Feng, Shihao Duan, Yi Yang and Yan Zhang in Therapeutic Advances in Gastroenterology</p
sj-docx-1-tag-10.1177_17562848221101722 – Supplemental material for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study
No full textSupplemental material, sj-docx-1-tag-10.1177_17562848221101722 for SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study by Yubin Cao, Jiaming Feng, Shihao Duan, Yi Yang and Yan Zhang in Therapeutic Advances in Gastroenterology</p
- …
